Cargando…
Ablation of C-type natriuretic peptide/cGMP signaling in fibroblasts exacerbates adverse cardiac remodeling in mice
Excessive activation of cardiac fibroblasts (CFs) in response to injury provokes cardiac fibrosis, stiffness, and failure. The local mediators counterregulating this response remain unclear. Exogenous C-type natriuretic peptide (CNP) exerts antifibrotic effects in preclinical models. To unravel the...
Autores principales: | Werner, Franziska, Prentki Santos, Estefania, Michel, Konstanze, Schrader, Hanna, Völker, Katharina, Potapenko, Tamara, Krebes, Lisa, Abeßer, Marco, Möllmann, Dorothe, Schlattjan, Martin, Schmidt, Hannes, Skryabin, Boris V., Špiranec Spes, Katarina, Schuh, Kai, Denton, Christopher P., Baba, Hideo A., Kuhn, Michaela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371345/ https://www.ncbi.nlm.nih.gov/pubmed/37227779 http://dx.doi.org/10.1172/jci.insight.160416 |
Ejemplares similares
-
C-type natriuretic peptide moderates titin-based cardiomyocyte stiffness
por: Michel, Konstanze, et al.
Publicado: (2020) -
Natriuretic peptides and cGMP in metabolic disease
por: Collins, Sheila
Publicado: (2015) -
C-type natriuretic peptide prevents angiotensin II-induced cardiac remodelling and dysfunction
por: Roloff, Konstanze, et al.
Publicado: (2015) -
Natriuretic peptides, via GC-A/cGMP, moderate hypoxia-induced VEGF release from astrocytes and thereby pathological neovascularization in the retina
por: Spiranec, Katarina, et al.
Publicado: (2015) -
Modulating cGMP in heart failure by novel natriuretic peptides
por: Burnett, John C
Publicado: (2009)